What’s the current market cap for Ryan Specialty Group stock?

Ryan Specialty Group (RYAN) has a market cap of $5.4bn as of July 04, 2026.

What is the P/E ratio for Ryan Specialty Group stock?

The price to earnings (P/E) ratio for Ryan Specialty Group (RYAN) stock is 54.07 as of July 04, 2026.

Does Ryan Specialty Group stock pay dividends?

Yes, the Ryan Specialty Group (RYAN) stock pays dividends to shareholders. As of July 04, 2026, the dividend rate is $0.5 and the yield is 1.24%. Ryan Specialty Group has a payout ratio of 58.94% on a trailing twelve-month basis.

When is the next Ryan Specialty Group dividend payment date?

The next Ryan Specialty Group (RYAN) dividend payment date is unconfirmed.

What is the beta indicator for Ryan Specialty Group?

Ryan Specialty Group (RYAN) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Ryan Specialty Group stock | $RYAN Share Price

About Ryan Specialty Group

Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.

Ticker

$RYAN

Sector

Finance

Primary listing

NYSE

Employees

6,144

Headquarters

Chicago, United States

Website

www.ryanspecialty.com

RYAN Metrics

BasicAdvanced

$5.4bn

54.07

$0.78

0.64

$0.50

1.24%

Bulls say / Bears say

Ryan Specialty delivered Q1 2026 revenue of $795.2 million, a 15.2% year-over-year increase, driven by robust demand across its specialty insurance products (SEC).

Adjusted diluted EPS rose 20.5% year-over-year to $0.47, beating consensus estimates by $0.04, underscoring operational efficiency gains and pricing power (MarketBeat).

The company swung to GAAP net income of $40.6 million in Q1 2026 from a loss of $4.4 million a year earlier, highlighting significant bottom-line improvement (StockTitan).

Management revised its full-year 2026 organic revenue growth guidance down to mid-single digits (4%–6%) and projected adjusted EBITDAC margin compression of 100–150 basis points, indicating margin pressure ahead (Yahoo Finance).

Ryan Specialty’s shares hit a 52-week low of $33.02 on March 25, 2026, marking a nearly 49% decline over the past year amid rising investor skepticism (Investing.com).

Shares closed down more than 11% on May 1, 2026 after management’s downward revision of 2026 guidance, reflecting a sell-the-news reaction despite the Q1 beat (The Insurer).

Data summarised monthly by Lightyear AI. Last updated on 17 Jun 2026.

RYAN News

AllArticlesVideos

Ryan Specialty to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Business Wire·2 days ago

RT Specialty Announces Planned Leadership Succession

Business Wire·1 week ago

RYAN Investors Have Opportunity to Join Ryan Specialty Holdings, Inc. Fraud Investigation with the Schall Law Firm

Business Wire·1 month ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.